Tamoxifen: A Protein Kinase C Inhibitor to Treat Mania A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials

@article{Talaei2016TamoxifenAP,
  title={Tamoxifen: A Protein Kinase C Inhibitor to Treat Mania A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials},
  author={A. Talaei and M. Pourgholami and H. Khatibi-Moghadam and F. Faridhosseini and F. Farhoudi and Arash Askari-Noghani and R. Sadeghi},
  journal={Journal of Clinical Psychopharmacology},
  year={2016},
  volume={36},
  pages={272–275}
}
Objective The aim of this study was to conduct a systematic review of literature to retrieve all randomized controlled trials that evaluated the efficacy of tamoxifen on manic mood episodes and meta-analyze their quantitative results. Methods Four electronic databases were systematically searched from their inception to March 2014: PubMed, Cochrane Library (Cochrane Central Register of Controlled Trials), Scopus, and PsychINFO. Pooled difference in means of changes in mania scores and pooled… Expand
Tamoxifen for bipolar disorder: Systematic review and meta-analysis
TLDR
Tamoxifen appears to be a promising potential treatment for episodes of mania, and future studies could investigate its effects as an adjunct to dopamine antagonists for improved anti-manic efficacy, and establish its longer term effects on mood, particularly depression and relapse. Expand
Endoxifen: A New, Protein Kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.
TLDR
Endoxifen at a low daily dose of 8 mg was as efficacious and safe in patients with BPD I acute manic episodes with/without mixed features and changes in Clinical Global Impressions-Bipolar Disorder and Clinical Global Impression-Severity of Illness scores showed that treatment with endoxifens was well-tolerated. Expand
Prescribing Tamoxifen in Patients With Mood Disorders
TLDR
Patients with a history of mood disorders may require a close clinical surveillance during tamoxifen use, and the use of tamoxIFen as an antimanic agent in psychiatric settings requires caution, as available evidence came from small-sample studies with short observation time. Expand
Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
  • M. Khan
  • Medicine
  • International journal of endocrinology
  • 2018
TLDR
Results together with potent neurocognitive, neuroprotective, and cardiometabolic properties suggest that selective estrogen receptor modulators (SERMs) could be the potential targets for designing effective and safer therapies for psychiatric disorders. Expand
Slim and Euthymic Tamoxifen and Aripiprazole in Bipolar Disorder: A Case Report.
TLDR
A case of a bipolar patient who initiated tamoxifen after a breast cancer diagnosis is reported, aiming to highlight the hypothesized positive impact of tamoxIFen on the progression of the disorder and a possible combination therapy with aripiprazole. Expand
Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature
TLDR
The current understanding identifies the PKC pathway as a potential therapeutic avenue for BD and presents recent advances from preclinical and clinical studies that further support the role of PKC. Expand
Pharmacological treatment of adult bipolar disorder
We summarize evidence supporting contemporary pharmacological treatment of phases of BD, including: mania, depression, and long-term recurrences, emphasizing findings from randomized, controlledExpand
How promising is neuroactive steroid drug discovery?
TLDR
This editorial explores a promising area of research: the investigation of neuroactive steroids (NASs), which are promising with respect to potential effectiveness on new targets than those explored so far. Expand
Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
TLDR
The in vitro, in vivo, and mechanistic studies of the anti-infective activity of tamoxifen, toremifene, clomiphene, and their analogs are reviewed and the pharmacologic properties of this privileged scaffold are discussed and its potential utility in treating infectious diseases is discussed. Expand
Tamoxifen and amphetamine abuse: Are there therapeutic possibilities?
TLDR
The hypothesis that tamoxifen, or an analog, could be used therapeutically to reduce amphetamine abuse in addition to treating mania is presented. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 18 REFERENCES
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.
TLDR
Investigating whether antimanic effects can be achieved with a protein kinase C inhibitor in subjects with mania found that it significantly decreased manic symptoms within a short period of time and showed significant improvement in mania. Expand
Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.
TLDR
Tamoxifen demonstrated antimanic properties and was remarkably well tolerated, and the findings encourage further clarification of the role of PKC in the pathophysiologic mechanism of bipolar I disorder and development of novel anti-PKC agents as potentialantimanic or mood-stabilizing agents. Expand
A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania
TLDR
Adjunctive therapy with MPA may be a potentially useful new treatment for persistent mania, leading to a greater and more rapid resolution of symptoms compared with mood stabiliser treatment alone. Expand
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
TLDR
The results demonstrate that the combination of tamoxifen with lithium was superior to lithium alone for the rapid reduction of manic symptoms. Expand
A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder
TLDR
The women who received tamoxifen exhibited significant improvement in symptoms of mania from baseline to final assessment compared with the placebo group, and the MPA group improved more than the placebo groups. Expand
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
TLDR
It is confirmed that tamoxifen can cause potentially malignant changes in the endometrium of postmenopausal women. Expand
Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen
TLDR
It is concluded that clinical depression as a side effect of tamoxifen therapy may be more common than previously believed and should be further rigorously investigated to confirm or deny the clinical impressions. Expand
Tamoxifen in the treatment of breast cancer.
  • S. Legha
  • Medicine
  • Annals of internal medicine
  • 1988
TLDR
A significant increase in the disease-free survival of postmenopausal women treated with tamoxifen is shown, particularly in patients with hormone-receptor-positive tumors. Expand
Successful Combined Therapy with Tamoxifen and Lithium in a Paradoxical Sleep Deprivation‐Induced Mania Model
TLDR
The findings suggest that lithium and tamoxifen exert reversal effects against PSD‐induced hyperactivity in mice and provides support for an alternative treatment of individuals who either do not respond adequately or cannot tolerate the adverse effects associated with therapeutic doses of lithium. Expand
Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta‐analysis of randomized placebo‐controlled trials
The aim of this research was to perform a systematic review to identify all randomized controlled trials (RCTs) evaluating the efficacy and safety of add‐on celecoxib for treatment of depressive moodExpand
...
1
2
...